CD47 and neoplasm: The cell-surface expression of CD47 was also enhanced in tumors treated with gels containing Dox-iRGD and CpG compared to untreated tumors (Supplementary Fig. 12a, b), presumably as part of the immune evasion mechanism of tumor cells in response to the boosted immune responses.